Screen Shot 2019-06-20 at 2.30.50 PM.png

Solid. Experienced. Motivated.

Led by a team of cross-functional domain experts. 



CIO & Managing Partner

Mr. Sarrazin is Chief Investment Officer and Managing Partner of the Autism Impact Fund where he oversees the firm and leads AIF’s Life Sciences practice. Rob’s career as a longtime healthcare investor, private equity partner and corporate development executive includes decades of experience overseeing a large portfolio of control investments, including corporate strategic transactions and over 30+ middle market growth acquisitions under multiple private equity funds.

  • LinkedIn
Ashok Srinivasan.jpg

An innovative and patient-oriented scientist, Ashok Srinivasan has an extensive history of leadership in clinical and basic science.

As the Translational Research Scientist for NSABP Foundation/NRG Pittsburgh, Ashok has dedicated the past seven years to translating scientific advances to clinical trials, supporting new technology and therapeutic advancements for breast and colorectal cancer. In this role, Ashok has consulted as a molecular genetics / genomics expert in developing scientific rationales for 10+ clinical trials and educated clinical trialists on emerging trends and best practices in

oncology research. 

  • LinkedIn

Kelly Patterson, Head of Investor Relations & Fund Administration, is responsible for managing all relationship activity, in addition to fund administration, for AIF.  Kelly previously worked for 18+ years in the professional sports and entertainment managing key corporate and consumer products partners. 

Kelly holds a B.A. in fine arts from Colby College where she played ice hockey.  She currently lives in Far Hills, NJ with her husband, newborn son and two dogs. 


Mr. Male is Co-Founder and Managing Partner of the Autism Impact Fund where he oversees the firm and leads the Business Services practice. Chris has over ten years experience leading venture and middle-market equity financing across business services, impact, and real estate, most recently as Managing Director of RBG Capital, LLC, his family's private investment arm.

  • LinkedIn

Katie Mangialardi, Associate, invests on behalf of the firm’s Life Sciences and Life Span Services divisions, and has spent her career working at the intersection of healthcare and finance. Katie was previously an Associate at J.P.Morgan, where she worked across both Derivatives Sales and Acquisition Leveraged Finance.

Katie holds a B.S. in Biology of Global Health from Georgetown University, where she was a George F. Baker Scholar. She resides in New York.

  • LinkedIn


President, Samsung Corporate Strategy Group

Philanthropist, Frist Center for Autism and Innovation

at Vanderbilt University

  • LinkedIn

Vice Chairman,

Mind & Life Institute

  • LinkedIn

Founder & CEO, Quartet, Accretive, The World Bank, McKinsey

  • LinkedIn

Healthcare Investor & Entrepreneur

Elizabeth Horn

Founder & CEO


AIF Founding LP

  • LinkedIn

Venture Capitalist

Emergence, Moai Capital

  • LinkedIn

CEO, Uber

  • LinkedIn

CEO & Founder, CPI

AIF Co-Founder & Executive Advisor

  • LinkedIn

Sean O'Sullivan

SOSV (IndieBio, Hax)

AIF Founding LP

  • LinkedIn

Partner, Dominus Capital

  • LinkedIn

“Venture capital is the accelerant that brings breakthrough technologies into markets. With millions of kids

and adults suffering from severe medical and  physiological challenges due to autism,

now is the time for the Autism Impact Fund.”

- Sean O’Sullivan, AIF Advisor & Founding LP


David Amaral.jpg

David Amaral, PhD

Director of the Autism Center of Excellence at UC Davis

Sir Simon Baron-Cohen, PhD

Director of the Autism Research Centre, University of Cambridge

Director of Autism Research, Arkansas Children's Hospital

Co-Founder, Mindstrong, NIH

  • LinkedIn
  • LinkedIn
  • LinkedIn
  • LinkedIn
Krishnan Nandabalan, PhD.jpg

Krishnan Nandabalan, PhD

  • LinkedIn

Ian Marks

Global VP Life Sciences, Salesforce, GSK, Novartis, Roche

  • LinkedIn

Alison Singer

Co-Founder & President, 

Autism Science Foundation

  • LinkedIn

Larry Derose

Founder and CEO, AdvaStim, Inc.

  • LinkedIn
Sir Simon Baron-Cohen, PhD.jpg

Bold strategy + Biology + Technology = Audacious goal achieved.